Clinical Trial Update: Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing artemisinin-based antimalarial combinations in Cameroon has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: University of Yaounde 1 | Conditions: Malaria | Phase 3 | Status: COMPLETED